Blueprint to Close the Women%E2%80%99s Health Gap 2025

25. World Health Organization. (2024). Breast cancer. https://www.who.int/news-room/fact-sheets/detail/breast-cancer 26. Arnold, M., et al. (2022, December). Current and future burden of breast cancer: Global statistics for 2020 and 2040. Breast, 66, 15–23. https://pubmed.ncbi.nlm.nih.gov/36084384/ 27. Susan G. Komen. (2024). Research: Our research impact. https://www.komen.org/about-komen/our-impact/breast- cancer/research 28. Caswell-Jin, J. L., et al. (2024, January 16). Analysis of breast cancer mortality in the U.S. – 1975 to 2019. JAMA, 281(4), 1–10. https://jamanetwork.com/journals/jama/fullarticle/2813878 29. World Health Organization. (2021). The Global Breast Cancer Initiative. https://www.who.int/initiatives/global-breast- cancer-initiative 30. Goel, M. S., et al. (2023, April 21). Neighborhood disadvantage and breast cancer-specific survival. JAMA Network Open, 6(4), 1–10. https://jamanetwork.com/journals/jamanetworkopen/fullarticle/2804100 31. Shariff-Marco, S., et al. (2014, May). Impact of neighborhood and individual socioeconomic status on survival after breast cancer varies by race/ethnicity: The Neighborhood and Breast Cancer Study. Cancer Epidemiology, Biomarkers & Prevention, 23(5), 793–801. https://pubmed.ncbi.nlm.nih.gov/24618999/ 32. Ford, N. D., et al. (2022, April 29). Hypertensive disorders in pregnancy and mortality at delivery hospitalization – United States, 2017–2019. Morbidity and Mortality Weekly Report (MMWR), 71(17), 585–591. https://pubmed.ncbi.nlm.nih. gov/35482575/ 33. Centers for Disease Control and Prevention. (2022, October 25). Preeclampsia, genomics and public health. https://blogs.cdc.gov/genomics/2022/10/25/preeclampsia/ 34. Clark, S. L., et al. (2023, May). Gestational hypertension and “severe” disease: Time for a change. American Journal of Obstetrics and Gynecology, 228(5), 547–552. https://www.ajog.org/article/S0002-9378(22)02168-8/abstract 35. Brohan, M. P ., et al. (2023, September). Hypertensive disorders of pregnancy and long-term risk of maternal stroke – a systematic review and meta-analysis. American Journal of Obstetrics and Gynecology, 229(3), 248–268. https://www. ajog.org/article/S0002-9378(23)00197-7/ 36. Brown, J. C., Gerhardt, T. E., & Kwon, E. (2023, January 23). Risk factors for coronary artery disease. NIH. StatPearls [Internet]. https://www.ncbi.nlm.nih.gov/books/NBK554410/ 37. Hwang, J. W., et al. (2015, October). The risk factors that predict chronic hypertension after delivery in women with a history of hypertensive disorders of pregnancy. Medicine, 94(42), e1747. https://doi.org/10.1097/ MD.0000000000001747 38. Koopmans, C. M., et al. (2014, February 14). Prediction of postpartum haemorrhage in women with gestational hypertension or mild preeclampsia at term. Acta Obstetricia et Gynecologica Scandinavica. https://obgyn.onlinelibrary. wiley.com/doi/10.1111/aogs.12352 39. World Health Organization. (2023). WHO Postpartum Haemorrhage Summit. https://www.who.int/news-room/events/ detail/2023/03/07/default-calendar/who-postpartum-haemorrhage-summit 40. Ibid. 41. Abdollahpour, S., et al. (2019, November 7). The needs of women who have experienced “maternal near miss”: A systematic review of literature. BMC Pregnancy and Childbirth, 24(6), 417–427. https://pmc.ncbi.nlm.nih.gov/articles/ PMC6875890/ 42. World Health Organization. (2024, April 26). Maternal mortality. https://www.who.int/news-room/fact-sheets/detail/ maternal-mortality 43. Romero-Gutiérrez, G., Espitia-Vera, A., Ponce-Ponce de León, A. L., & Huerta-Vargas, L. F. (2007, March). Risk factors of maternal death in Mexico. Birth, 34(1), 21–25. https://pubmed.ncbi.nlm.nih.gov/17324174/#:~:text=Results%3A%20 The%20maternal%20mortality%20ratio,and%20septic%20shock%20(10.9%25); Ehiri, J., et al. (2018, April 25). Emergency transportation interventions for reducing adverse pregnancy outcomes in low- and middle-income countries: A systematic review protocol. Systematic Reviews, 7(1), 65. https://doi.org/10.1186/s13643-018-0729-2 44. World Economic Forum & McKinsey Health Institute. (2024). Closing the women’s health gap: A $1 trillion opportunity to improve lives and economies. https://www.mckinsey.com/mhi/our-insights/closing-the-womens-health-gap-a-1-trillion- dollar-opportunity-to-improve-lives-and-economies 45. Essity. (2024). Closing the menstrual health gap. https://www.essity.com/company/breaking-barriers-to-well-being/ stories/closing-the-menstrual-health-gap/ 46. Chumpalova, P ., et al. (2020, January 15). Prevalence and clinical picture of premenstrual syndrome in females from Bulgaria. Annals of general psychiatry, 19, 3. https://doi.org/10.1186/s12991-019-0255-1 47. Guidpally, P ., & Sharma, G. (2024). Premenstrual syndrome. NIH. StatPearls [Internet]. https://www.ncbi.nlm.nih.gov/ books/NBK560698/ 48. Schoep, M. E. (2019). Productivity loss due to menstruation-related symptoms: A nationwide cross-sectional survey among 32,748 women. BMJ Open, 9(6), e026186. https://bmjopen.bmj.com/content/9/6/e026186 49. Reilly T., et al, (2024). The prevalence of premenstrual dysphoric disorder: Systematic review and meta-analysis. Journal of Affective Disorders, 349, 534–540, https://doi.org/10.1016/j.jad.2024.01.066 Blueprint to Close the Women’s Health Gap: How to Improve Lives and Economies for All 54